Fairscale Capital’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$6.41K	Sell	114 -3	-3%	-$169	﹤0.01%	345
2025 Q1	$3.98K	Hold	117	–	–	﹤0.01%	279
2024 Q4	$4.61K	Hold	117	–	–	﹤0.01%	273
2024 Q3	$5.5K	Sell	117 -91	-44%	-$4.28K	﹤0.01%	269
2024 Q2	$13.1K	Buy	+208	New	+$13.1K	0.01%	247